Parallel Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$90K Buy
373
+27
+8% +$6.52K ﹤0.01% 1405
2025
Q1
$84.3K Sell
346
-51
-13% -$12.4K ﹤0.01% 1350
2024
Q4
$130K Sell
397
-52
-12% -$17.1K ﹤0.01% 1133
2024
Q3
$150K Buy
449
+47
+12% +$15.7K ﹤0.01% 1044
2024
Q2
$110K Buy
402
+234
+139% +$63.9K ﹤0.01% 1134
2024
Q1
$58.1K Sell
168
-3
-2% -$1.04K ﹤0.01% 1421
2023
Q4
$55.2K Buy
171
+46
+37% +$14.9K ﹤0.01% 1391
2023
Q3
$44.8K Buy
125
+13
+12% +$4.66K ﹤0.01% 1444
2023
Q2
$42.5K Sell
112
-11
-9% -$4.17K ﹤0.01% 1483
2023
Q1
$58.9K Sell
123
-2
-2% -$958 ﹤0.01% 1301
2022
Q4
$52.6K Sell
125
-71
-36% -$29.9K ﹤0.01% 1257
2022
Q3
$82K Sell
196
-173
-47% -$72.4K ﹤0.01% 1040
2022
Q2
$183K Sell
369
-166
-31% -$82.3K 0.01% 715
2022
Q1
$310K Sell
535
-185
-26% -$107K 0.01% 566
2021
Q4
$544K Buy
720
+53
+8% +$40K 0.02% 417
2021
Q3
$498K Buy
667
+68
+11% +$50.8K 0.02% 406
2021
Q2
$386K Sell
599
-10
-2% -$6.44K 0.02% 455
2021
Q1
$348K Sell
609
-10
-2% -$5.71K 0.02% 452
2020
Q4
$361K Buy
619
+54
+10% +$31.5K 0.02% 400
2020
Q3
$291K Buy
565
+50
+10% +$25.8K 0.02% 433
2020
Q2
$232K Buy
515
+93
+22% +$41.9K 0.02% 490
2020
Q1
$147K Buy
422
+244
+137% +$85K 0.01% 550
2019
Q4
$66K Hold
178
0.01% 939
2019
Q3
$59K Sell
178
-13
-7% -$4.31K 0.01% 904
2019
Q2
$60K Hold
191
0.01% 831
2019
Q1
$58K Buy
191
+12
+7% +$3.64K 0.01% 801
2018
Q4
$41K Buy
179
+12
+7% +$2.75K 0.01% 826
2018
Q3
$52K Hold
167
0.01% 797
2018
Q2
$48K Hold
167
0.01% 737
2018
Q1
$42K Hold
167
0.01% 753
2017
Q4
$40K Hold
167
0.01% 771
2017
Q3
$42K Sell
167
-17
-9% -$4.28K 0.01% 741
2017
Q2
$43K Buy
184
+45
+32% +$10.5K 0.01% 730
2017
Q1
$31K Sell
139
-28
-17% -$6.25K 0.01% 792
2016
Q4
$30K Buy
+167
New +$30K 0.01% 726